In Escherichia coli, the de novo synthesis of the coenzyme nicotinamide adenine dinucleotide (NAD) proceeds from aspartate and a threecarbon compound (4) via quinolinate and nicotinate mononucleotide (1) , rather than from tryptophan as in mammals and Neurospora (3) . In addition to this de novo pathway, E. coli can also utilize nicotinate or nicotinamide for NAD synthesis via a salvage pathway (reference 2; Fig. 1 ). Any mutation causing a block in any synthetic reaction preceding nicotinate mononucleotide in the de novo pathway is phenotypically expressed as a nutritional requirement that can be satisfied by exogenously supplied nicotinate or nicotinamide. The present study reports on the utilization of NAD to satisfy the requirement of such mutants.
Mutations affecting a step in the de novo pathway are present in E. coil strains 126 and W-3899. The mutation in 126 (a gift from J. Imsande) involves the loss of quinolinate phosphoribosyl transferase activity. Such mutations reside in a locus that shall be designated nicC in this study; nicC mutations map within 1 min from leucine on the side opposite threonine. The mutation in W-3899 maps in the nicB locus positioned by Taylor and Trotter (6) . These mutants grow on minimal medium supplemented with NAD, as well as with either nicotinate or nicotinamide ( Table 1) . The question remains, however, as to whether NAD enters cells in an intact and therefore functional form; if it does, then double mutants with one block in the de novo pathway and a second lesion in the salvage pathway should be able to grow on NADsupplemented medium. Conversely, if utilization of NAD proceeds via the salvage pathway, then 1 
